Literature DB >> 990786

Two cases of ethambutol nephrotoxicity.

J Collier, A M Joekes, P E Philalithis, F D Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 990786      PMCID： PMC1689465          DOI： 10.1136/bmj.2.6044.1105-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  Clinical pharmacology of ethambutol.

Authors:  V A PLACE; J P THOMAS
Journal:  Am Rev Respir Dis       Date:  1963-06

2.  Peripheral neuropathy with ethambutol.

Authors:  P Tugwell; S L James
Journal:  Postgrad Med J       Date:  1972-11       Impact factor: 2.401

3.  [Comparison between renal clearances with inulin and para-aminohippuric acid and blood concentrations of ethambutol].

Authors:  L Anex; G Favez; C Willa
Journal:  Schweiz Med Wochenschr       Date:  1972-01-29

4.  Ethambutol and a false-positive screening test for phaeochromocytoma.

Authors:  R Gabriel
Journal:  Br Med J       Date:  1972-08-05

5.  Studies on the mechanism of ethambutol-induced hyperuricemia.

Authors:  A E Postlethwaite; W N Kelley
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

6.  Hyperuricemia due to ethambutol.

Authors:  A E Postlethwaite; A G Bartel; W N Kelley
Journal:  N Engl J Med       Date:  1972-04-06       Impact factor: 91.245

Review 7.  Drug-induced lupus syndromes.

Authors:  D Alarcón-Segovia
Journal:  Mayo Clin Proc       Date:  1969-09       Impact factor: 7.616

8.  Ethambutol absorption, excretion and dosage in patients with renal tuberculosis.

Authors:  I Strauss; F Erhardt
Journal:  Chemotherapy       Date:  1970-03       Impact factor: 2.544

9.  Renal effects of antituberculous antibiotics.

Authors:  W P Raab
Journal:  Pathol Microbiol (Basel)       Date:  1970

Review 10.  Acute renal failure after rifampicin: a case report and survey of the literature.

Authors:  R Nessi; G L Bonoldi; B Redaelli; G di Filippo
Journal:  Nephron       Date:  1976       Impact factor: 2.847
  10 in total
  5 in total

1.  Interstitial nephritis.

Authors:  A J Dixon; C G Winearls; M S Dunnill
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

2.  Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.

Authors:  M Masud Parvez; Jin Ah Jung; Ho Jung Shin; Dong Hyun Kim; Jae-Gook Shin
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

3.  Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.

Authors:  Xiaolei Pan; Li Wang; Dirk Gründemann; Douglas H Sweet
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

4.  Comprehensive Substrate Characterization of 22 Antituberculosis Drugs for Multiple Solute Carrier (SLC) Uptake Transporters In Vitro.

Authors:  M M Parvez; Nazia Kaisar; Ho Jung Shin; Yoon Jae Lee; Jae-Gook Shin
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

5.  Antitubercular effect of 8-[(4-Chloro phenyl) sulfonyl]-7-Hydroxy-4-Methyl-2H-chromen-2-One in guinea pigs.

Authors:  Parvati B Patel; Tejas K Patel; Seema N Baxi; Hemangini R Acharya; Chandrabhanu Tripathi
Journal:  J Pharmacol Pharmacother       Date:  2011-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.